With hemoglobin 10.1 g/dL, hematocrit 30.4 %, total leukocyte count 8,800/µL (neutrophils 73 %, lymphocytes 24 %, eosinophils 3 %), platelet count 437,000/µL, MCV 79.4 fL, MCH 23.3 pg, and MCHC 29.3 g/dL, what is the most likely diagnosis and how should it be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Microcytic Hypochromic Anemia - Iron Deficiency Anemia

This patient has iron deficiency anemia (IDA) and requires serum ferritin measurement for confirmation, followed by oral iron supplementation and investigation for the underlying cause of iron loss.

Diagnosis

The laboratory values reveal:

  • Anemia: Hemoglobin 10.1 g/dL (below normal threshold of 12-13 g/dL) 1
  • Microcytosis: MCV 79.4 fL (reduced, normal >80 fL)
  • Hypochromia: MCH 23.3 pg and MCHC 29.3 g/dL (both reduced)
  • Reactive thrombocytosis: Platelets 437,000/µL (elevated, commonly seen in IDA)

The combination of low hemoglobin with reduced MCV, MCH, and MCHC is pathognomonic for microcytic hypochromic anemia. MCH is actually a more reliable marker of iron deficiency than MCV alone, as it is less dependent on storage conditions and the counting machine used 1. The elevated platelet count is a typical reactive finding in iron deficiency.

Immediate Diagnostic Steps

Confirm iron deficiency with serum ferritin - this is the single most useful marker of IDA 1. Additional tests to order:

  • Serum ferritin (most important)
  • Transferrin saturation (helpful if false-normal ferritin suspected due to inflammation)
  • Consider reticulocyte count to assess bone marrow response

Important Caveat

If iron studies are equivocal but clinical suspicion is high, a good response to iron therapy (Hb rise ≥10 g/L within 2 weeks) is highly suggestive of absolute iron deficiency 1. This can serve as both diagnostic and therapeutic.

Management Algorithm

1. Initiate Oral Iron Therapy

Start empiric oral iron supplementation while awaiting confirmatory tests, given the clear microcytic hypochromic picture.

2. Investigate the Source of Iron Loss

Investigation should be considered at any level of anemia in the presence of iron deficiency 1. The case is stronger with more severe degrees of anaemia, as serious underlying GI pathology is more likely.

Key investigations needed:

  • Gastrointestinal evaluation: Upper and lower GI endoscopy (especially given this level of anemia warrants investigation for occult bleeding, malignancy)
  • Menstrual history (if female and menstruating)
  • Dietary assessment for inadequate intake
  • Celiac serology (tissue transglutaminase antibodies)
  • Stool for occult blood

3. Monitor Response

Recheck CBC in 2 weeks:

  • Expected response: Hb rise ≥10 g/L confirms iron deficiency 1
  • If no response, reconsider diagnosis or investigate for ongoing blood loss

Critical Pitfalls to Avoid

  • Do not delay investigation: While this hemoglobin level (10.1 g/dL) may seem "mild," investigation should not be deferred, as colorectal cancer can present at any level of anemia with iron deficiency 1
  • Beware of concurrent deficiencies: Co-existing vitamin B12 or folate deficiency can mask microcytosis, making MCV appear falsely normal 2. However, this patient's clear microcytosis makes this less likely
  • Chronic disease can reduce sensitivity: Both MCV and MCH lose sensitivity for iron deficiency in the presence of chronic inflammatory conditions 1

White Blood Cell Parameters

The leukocyte differential (neutrophils 73%, lymphocytes 24%, eosinophils 3%) is within normal limits and does not suggest infection, inflammation, or hematologic malignancy requiring immediate attention. The total WBC of 8,800/µL is normal 3.

Related Questions

Given a CBC with white blood cell count 3.8 ×10⁹/L, red blood cell count 4.56 ×10⁶/L, hemoglobin 13.9 g/dL, mean corpuscular hemoglobin concentration 32.7 g/dL, absolute monocytes 0.22 ×10⁹/L, and absolute eosinophils 0.07 ×10⁹/L, what is the clinical significance and recommended management?
How should I interpret a complete blood count that shows a low red blood cell count, mildly elevated mean corpuscular volume, and increased mean corpuscular hemoglobin and mean corpuscular hemoglobin concentration?
Is my complete blood count, with a white blood cell count of 6.09 ×10⁹/L, hemoglobin 13.6 g/dL, platelet count 373 ×10⁹/L, neutrophils 44.7 % and lymphocytes 37.8 %, within normal limits?
Should a repeat complete blood count (CBC) be performed for a patient with mild leukocytosis and neutrophilia?
How concerned should I be about a complete blood count (CBC) showing white blood cell count (WBC) 16.0 ×10⁹/L, red blood cell count (RBC) 2.77 ×10¹²/L, hemoglobin 8.5 g/dL, hematocrit 26.7 %, mean corpuscular volume (MCV) 96.4 fL, red cell distribution width (RDW) 24.9 %, platelet count 178 ×10⁹/L, mean platelet volume (MPV) 12.3 fL, and nucleated red blood cells (NRBC) 16.5 % (absolute 2.6 ×10⁹/L)?
What is the recommended treatment approach for bipolar disorder in children and adolescents?
Between etoricoxib (nucoxia) and diclofenac (rutoheal), which is more effective for reducing inflammation and swelling?
Can gabapentin be initiated at 100 mg daily in a chronic kidney disease patient on dialysis who has paresthesia pain following an epidural steroid injection?
What are the recommended pathological investigations for suspected breast carcinoma?
What is the appropriate gabapentin dosing regimen for a patient who undergoes hemodialysis daily?
In a patient with a T1 N0, well‑differentiated oral cavity carcinoma completely excised with clear margins, having worst pattern of invasion grade 2 and a depth of invasion of 5 mm, is postoperative adjuvant therapy indicated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.